Sort
15,842 grants matching “pancreatic cancer”
Targeting tumor architecture as a novel therapeutic strategy for pancreatic cancer
$445,861Matteo Ligorio · Ut Southwestern Medical Center · R37 · FY2024 · CA
Project 2 NF-#B regulation in muscle wasting and pancreatic cancer-induced cachexia
$445,854Denis C Guttridge · Medical University Of South Carolina · P01 · FY2021 · CA
Pathophysiology, Epidemiology, and Prevention of Pancreatogenic Diabetes
$445,753Stephen J Pandol · Cedars-Sinai Medical Center · U01 · FY2017 · DK
CANCER RISK DETECTION BY MUTATIONAL LOAD DISTRIBUTION AN
$445,696Yale University · U01 · FY2000 · CA
Pixel-accurate oncologic therapy using a scanning fiber endoscope
$445,443Eric J Seibel · University Of Washington · R01 · FY2009 · EB
Case-only Cancer Clustering for Mobile Populations
$445,375Geoffrey M. Jacquez · Biomedware · R44 · FY2010 · CA
Targeting Metabolic Crosstalk in Pancreatic Cancer
$445,319Christopher J. Halbrook · University Of California-Irvine · R37 · FY2025 · CA
CELLULAR PATHWAYS AFFECTING ONCOLYTIC VIRUS-HOST INTERACTIONS IN CANCER
$445,303Valery Zurabovich Grdzelishvili · University Of North Carolina Charlotte · R15 · FY2016 · CA
Camptothecin Analogs for Cancer Therapy
$444,873Lee Roy Morgan · Dekk-Tec, Inc. · R44 · FY2010 · CA
Clinical Trials for Imaging and Therapy
$444,757Suzanne Elizabeth Lapi · Proteogenomics Research Instit/Sys/ Med · P01 · FY2021 · CA
Prospective Study of Human Oral Microbiome and Pancreatic Cancer Risk
$444,726Jiyoung Ahn · New York University School Of Medicine · R01 · FY2014 · CA
Exploiting Integrin Signaling to Overcome Resistance to Immunotherapy
$444,655David G Denardo · Washington University · R01 · FY2021 · CA
Epigenetic Drivers of Cancer Progression
$444,608Andrew P Feinberg · Johns Hopkins University · R01 · FY2015 · CA
Anti-tumor potential of temperature-sensitive p53 mutants
$444,591Jiandong Chen · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA
Anti-tumor potential of temperature-sensitive p53 mutants
$444,590Jiandong Chen · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · CA
Targeting Epigenomic Regulators at the Replication Fork in PDAC
$444,584Gwen Lomberk · Medical College Of Wisconsin · R01 · FY2023 · CA
Quantitative In Vivo 68Ga-Fibroblast-Activation-Protein-Inhibitors (FAPI)-46 PET Imaging of Cancer-Associated Fibroblasts (CAFs) in Pancreatic Ductal Adenocarcinoma (PDA)
$444,504Ajit Harishkumar Goenka · Mayo Clinic Rochester · R01 · FY2024 · CA
Multifunctional immunoPET tracers for pancreatic and prostate cancer
$444,176Anna M Wu · University Of California Los Angeles · R01 · FY2016 · CA
Multifunctional immunoPET tracers for pancreatic and prostate cancer
$444,176Anna M Wu · University Of California Los Angeles · R01 · FY2017 · CA
Characterizing the fibrogenic role of NADPH oxidase 1 in the transition from chronic pancreatitis to pancreatic cancer
$444,000Maria Eugenia Sabbatini · Augusta University · R15 · FY2022 · CA
Surgical Studies of GI Peptides - Mechanisms of Action
$443,937University Of Texas Medical Br Galveston · R01 · FY2003 · DK
The Stanford Clinical Center for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer
$443,872Walter Gwang-Up Park · Stanford University · U01 · FY2023 · DK
3D MULTISCALE ANALYSIS OF MALIGNANT PROGRESSION IN HUMAN PANCREATIC CANCER
$443,787The Johns Hopkins University · · FY2022 · Defense Health Agency
Mechanisms of action of the Smyd3 methyltransferase in cancer cells
$443,781Or P. Gozani · Stanford University · R01 · FY2014 · CA
Role of nonsense mediated RNA decay in pancreatic cancer
$443,663Mark Reid Philips · New York University School Of Medicine · R01 · FY2018 · CA